ABBV 全部观点

ABBV 这一页 2 条观点条目,其中 0 条方向发生变化。

在本页筛选
Mark Roussin, CPA发布 2026-09-27
《I LOVE These 3 Stocks — But I'm NOT Buying Yet》
$ABBV未站边
ABBV 基本面强劲且具备增长,但当前估值过高,不宜买入;等待更低价格/安全边际。

目前在我观察名单上的三只股票是 Apple、CrowdStrike 和 AbbVie。但我目前一只都不买。原因与它的业务活动无关,完全在于它的市场估值。

The three stocks currently on my watch list are Apple, CrowdStrike, and AbbVie. But I am not buying any of them at the moment. The reason has nothing to do with her business activities. It's all about its market valuations.

这是一个完全不同的投资情形,这也把我们引向今天名单上最令人意外的公司——AbbVie,代码 ABBV。这是我一直很喜欢的一只股票,也是我在钱包里持有时间最长的一只。

This is a completely different investment situation, which leads us to the most surprising company on today's list, AbbVie, symbol ABBV. This is a name I have always loved and it is the longest center I have kept in my wallet.

Ale's World of Stocks发布 2026-09-27
《Saudi Arabia is Secretly Loading Up on THESE 5 Stocks! 🚨》
$ABBV未站边
ABBV 处于历史高位、上行空间有限,因此当前不增持,仅持有现有仓位以获取股息收益。

我们从医疗保健板块的一个真正巨头开始,这是一只传统的防御性股票,为长期投资者创造利润、印钞。它就是生物制药巨头“AbbVie”,代码为ABBV,上个季度沙特央行将其押注翻倍,增持约90%,仅一个季度就花费了估计1400万美元。

We begin with a true giant in the healthcare sector , a traditional defensive stock that generates profits and prints money for long-term investors. It is the biopharmaceutical giant “AbbVie” , which carries the symbol ABBV, and on which the Saudi central bank doubled its bet last quarter, increasing its stake by about 90% and spending an estimated $14 million in just one quarter.

已经是最早的记录
其他股票的全部观点条目
把 $ABBV 加入我的股票30 天完整试用
开始试用